410 related articles for article (PubMed ID: 11014352)
1. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
2. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
4. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
5. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
7. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
8. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.
Damoiseaux J; Vaessen M; Knapen Y; Csernok E; Stegeman CA; Van Paassen P; Tervaert JW
Ann N Y Acad Sci; 2007 Aug; 1109():454-63. PubMed ID: 17785334
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
Takizawa M
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
[TBL] [Abstract][Full Text] [Related]
11. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
Chen M; Yu F; Wang SX; Zou WZ; Zhang Y; Zhao MH; Wang HY
Nephrol Dial Transplant; 2007 Jan; 22(1):139-45. PubMed ID: 16980322
[TBL] [Abstract][Full Text] [Related]
12. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
Zhang X; Jiang M; Chui J; Wang H; Ma J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.
Vassilopoulos D; Niles JL; Villa-Forte A; Arroliga AC; Sullivan EJ; Merkel PA; Hoffman GS
Arthritis Rheum; 2003 Apr; 49(2):151-5. PubMed ID: 12687504
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.
O'Donnell JL; Hayman MW; Spellerberg MB; McLellan AD; Brooksbank K; Chapman PT; Stamp LK
Pathology; 2007 Apr; 39(2):258-63. PubMed ID: 17454758
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
18. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
19. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
20. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions.
Russell KA; Wiegert E; Schroeder DR; Homburger HA; Specks U
Clin Immunol; 2002 May; 103(2):196-203. PubMed ID: 12027425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]